|
| Exchange Received Time 21/06/2018 16:04:43 Exchange Disseminated Time 21/06/2018 16:04:45 Time Taken 00:00:02 | This is to inform you that the Board of Directors of the Company ('Board') at its meeting held on June 21, 2018 has, inter alia, approved the Scheme of Amalgamation ('Scheme') under Sections 230-232 and other applicable provisions of the Companies Act, 2013 between the Company and its subsidiary company, Fermenta Biotech Limited, subject to other necessary statutory approvals including the approval of the National Company Law Tribunal Bench at Mumbai.
Other requisite details regarding the proposed Amalgamation in terms of SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 are provided in Annexure 1.
The Board meeting commenced at 12.30 pm and concluded at 3.50 pm. |
|
|